Citation Impact
Citing Papers
Photodynamic Therapy
1998 Standout
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
2006 Standout
The present and future role of photodynamic therapy in cancer treatment
2004 Standout
Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶
2004
Pyoderma gangrenosum: Classification and management
1996 Standout
Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients
2000
Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy
1993
Porphyrias
2010 Standout
Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria
2004 Standout
The biochemistry of heme biosynthesis
2008
Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity
1996
Photodynamic therapy for cancer
2003 Standout
Systematic Analysis of Molecular Defects in the Ferrochelatase Gene from Patients with Erythropoietic Protoporphyria
1998
An Analysis of 112 Acute Porphyric Attacks in Cape Town, South Africa
2005
ALCOHOL AND PORPHYRIN METABOLISM
2000
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Pyoderma gangrenosum: an updated review
2009 Standout
Photodynamic therapy of cancer: An update
2011 Standout
Photodynamic therapy: a new antimicrobial approach to infectious disease?
2004 Standout
Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization
2004 Standout
Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid
1997
5-Aminolevulinic acid-based photodynamic therapy
1997
Superficial Granulomafous Pyoderma
1991
Early Administration of Heme Arginate for Acute Porphyric Attacks
1993
Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.
1995
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Pyoderma gangrenosum, subcorneal pustular dermatosis and IgA paraproteinaemia
1986
Erythropoietic protoporphyria
1997
The cutaneous porphyrias: a review
1999
Photodynamic Therapy in Dentistry
2007 Standout
Photosensitized singlet oxygen and its applications
2002 Standout
BODIPY dyes in photodynamic therapy
2012 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy
1995 Standout
Inheritance in Erythropoietic Protoporphyria: A Common Wild-Type Ferrochelatase Allelic Variant With Low Expression Accounts for Clinical Manifestation
1999
Photodynamic therapy for polyps in familial adenomatous polyposis—a pilot study
1995
Works of Kaisa Timonen being referenced
Effects of haem arginate on variegate porphyria
1990
Four Novel Mutations in the Ferrochelatase Gene among Erythropoietic Protoporphyria Patients
1996
Skin morphology in porphyria cutanea tarda does not improve despite clinical remission
1991
Clinical and biochemical characteristics and genotype–phenotype correlation in Finnishvariegate porphyria patients
2002
Homozygous Variegate Porphyria: 20 y Follow-Up and Characterization of Molecular Defect
2001
Treatment of the Porphyrias
1994
Sustained high plasma 5‐aminolaevulinic acid concentration in a volunteer: no porphyric symptoms
1992
Skin changes in variegate porphyria
1990
Localized heat urticaria associated with a decrease in serum complement factor B (C3 proactivator)
1984